Here's a proactive measure to address a big problem in cancer treatment in India - cancer detected too late to be cured. The ministry of health is collaborating with PromOTE India, a non-profit initiative, to take practical oncology training and education to hundreds of medical colleges all over the country. The idea is to train … Continue reading Catch it young : Efforts to improve early diagnosis of cancer in India
Month: May 2012
India’s drug regulatory regime sucks. What now?
Not one person who has any claim to familiarity with India's pharmaceuticals landscape can pretend to be surprised by the findings of a recent report on the functioning of CDSCO - India's equivalent of the US FDA. However, the report performs a very important task which is putting together recent facts and evidence in the … Continue reading India’s drug regulatory regime sucks. What now?
It takes a village : What Ranbaxy’s Synriam tells us
Synriam, Ranbaxy's new anti-malarial drug combination, is the first new drug R&D project by an Indian generics company that's yielded a marketable drug. That's big in itself as various media reports have acknowledged. To me, its key value lies not so much in its "firstness." Its value is even greater as a case study - … Continue reading It takes a village : What Ranbaxy’s Synriam tells us